Biostatistics

Brent R. Logan, PhD 

Brent Logan, PhD Associate Professor Division of Biostatistics Department of Population Health PhD Statistics Northwestern University, 2001 Phone: 414-456-8849 Fax: 414-456-6513 EMAIL: blogan@mcw.edu Personal Page

Professor Brent Logan joined the Division of Biostatistics in the Summer of 2001. Dr. Logan is a biostatistician for the clinical trials network of the Center for International Bone Marrow Transplant Registery (CIBMTR) and a statistical consultant for the National Marrow Donor Program. He has research interests in multiple comparison procedures, clinical trial design, analysis of neuroimaging data, methods for analyzing multiple endpoints in clinical trials, and inference in dose-response studies.
 
Recent Publications:

Barker CC, Agovi MA, Logan B, Gupta V, Lazarus HM, Ballen KK, Hale GA, Frangoul H, Rizzo JD, and Pasquini MC, Obesity adversely affects survival of pediatric patients with severe aplastic anemia after hematopoietic cell transplantation, Oral Presentation, 51^st  ASH Annual Meeting and Exposition, New Orleans, LA, Dec 2009. 

Gupta V, Tallman MS, He W, Logan B, DiPersio JF, Bunjes DW, and Weisdorf DJ, Comparable disease-free and overall survival after “well-matched” unrelated donor and matched sibling donor transplantation in acute myeloid leukemia with adverse risk karyotype in first Complete remission–a report from the Acute Leukemia Working Committee of the Centre for International Blood and Marrow Transplant Research, Oral Presentation, 51^st  ASH Annual Meeting and Exposition, New Orleans, LA, Dec 2009. 

Horan J, Logan BR, Agovi MA, Lazarus HM, Bacigalupo A, Ballen K, Martino R, Juckett MB, Khoury HJ, Bredeson C, Gupta V, Smith FO, Hale G, Carabasi M, McCarthy PL, Rizzo JD, and Pasquini MC, Reducing the risk for transplant related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?, Oral Presentation, 51^st  ASH Annual Meeting and Exposition, New Orleans, LA, Dec 2009. 

Sabloff M, Chandy M,Wang Z, Logan B, Li C-K, Irfan SM, Eapen M, and Walters MC, Bone marrow transplantation from HLA-identical sibling for thalassemia, Poster, 51^st  ASH Annual Meeting and Exposition, New Orleans, LA, Dec 2009.

Marks DI, Ballen KK, Logan BR, Wang ZW, Sobocinski KA, Bacigalupo A, Burns LJ, Gupta V, Ho V, McCarthy P, Ringden O, Schouten HC, Seftel M, and Rizzo JD, The effect of smoking on allogenic transplant outcomes, Biol Blood Marrow Transplant; 15(10):1277-87, 2009.

Curry CV, Ewton AA, Olsen RJ, Logan BR, Preti HA, Liu YC, Perkins SL, and Chang CC, Prognostic impact of C-REL expression in diffuse large B-cell lymphoma, Journal of Hematopathology; 2(1):20-6, 2009.

Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, and Confer DL, Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: Beneficial effects of higher CD34+ cell dose, Blood; 114(13):2606-16, 2009.

Ratanatharathorn V, Logan B, Wang D, Horowitz M, Uberti JP, Ringden O, Gale RP, Khoury H, Arora M, Spellman S, Cutler C, Antin J, Bornhaüser M, Hale G, Verdonck L, Cairo M, Gupta V, Pavletic S; for the Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, USA, Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation, British Journal of Haematology; 145(6):816-24, 2009.

Alousi AM, Weisdorf DJ, Logan BR, Bolanos-Meade J, Carter S, Difronzo N, Pasquini M, Goldstein SC, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, and Levine JE, Etanercept, mycophenolate, denileukin or pentostatin plus corticosteroids for acute graft vs. host disease: A randomized phase II trial from the BMT CTN, Blood; [Epub ahead of print], 2009 May 14.

Devetten MP, Hari PN, Carreras J, Logan BR, van Besien K, Bredeson CN, Freytes CO, Gale RP, Gibson J, Giralt SA, Goldstein SC, Gupta V, Marks DI, Maziarz DI, Vose JM, Lazarus HN, and Anderlini P, Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma, Biology of Blood and Marrow Transplantation, 15(1):109-117, 2009

Pulsipher MA, Chitphakdithai P, Miller J, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson M, Kurian S, Klein JP, Horowitz MM, and Confer DL, Adverse events among 2408 unrelated donors of peripheral blood stem cells: Results of a prospective trial from the National Marrow Donor Program, Blood; 113 (15):3604-11, 2009.

PubMed Publications

Google Scholar Search